| Viatris Pharma GmbH - Posaconazol Viatris 40 mg/ml, Suspension zum Einnehmen | | 68271 | | 01 | | Posaconazol Viatris 40 mg/ml | | Suspension zum Einnehmen | | J02AC04 | | Posaconazole | | 19.07.2021 | | |
| | Composition | | posaconazolum 200 mg, acidum citricum monohydricum, natrii dihydrogenocitras anhydricus, natrii benzoas 10 mg, natrii laurilsulfas, simeticonum, methylcellulosum, acidum sorbicum, xanthani gummi, glycerolum, glucosum liquidum 2108.5 mg, E 171, aromatica (Kirschen), aqua purificata ad suspensionem pro 5 ml corresp. natrium 5.91 mg. | | Packungsbestandteile | | Suspension (orale) | | | | | | | | Principe actif | Concentr. |
|---|
| Posaconazole | 200mg / 5ml |
| | BAG: Principe actif | Concentr. |
|---|
| Posaconazole | 200 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Citrique Monohydre | | | | Acidum Sorbicum | | | | Aromatica (Kirschen) | | | | E 171 | | color. | | Glucosum Liquidum | 2108.5mg / 5ml | | | Glycerol | | | | Methylcellulosum | | | | Sodium Benzoate | 10mg / 5ml | | | Natrii Dihydrogenocitras Anhydricus | | | | Natrii Laurilsulfas | | | | Simeticone | | | | Xanthani Gummi | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 105 ml | 513.14 | 574.50 | B | LS | Non |
|
|
